Comparison 23. Oxytocin alone vs vaginal PGFalpha: all women.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Uterine hyperstimulation with FHR changes	1	23	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Caesarean section	3	280	Risk Ratio (M‐H, Fixed, 95% CI)	1.19 [0.65, 2.18]
3 Serious neonatal morbidity or perinatal death	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Cervix unfavourable or unchanged after 12/24 hours	1	62	Risk Ratio (M‐H, Fixed, 95% CI)	1.54 [0.50, 4.73]
5 Uterine hyperstimulation without FHR changes	3	291	Risk Ratio (M‐H, Fixed, 95% CI)	0.63 [0.20, 1.96]
6 Epidural analgesia	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	1.99 [1.31, 3.03]
7 Instrumental vaginal delivery	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	0.84 [0.52, 1.35]
8 Perinatal death	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
9 Vomiting	3	291	Risk Ratio (M‐H, Fixed, 95% CI)	2.09 [0.40, 11.05]
10 Diarrhoea	3	291	Risk Ratio (M‐H, Fixed, 95% CI)	0.06 [0.00, 0.98]
11 Chorioamnionitis	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	0.77 [0.05, 10.85]
12 Endometritis	1	202	Risk Ratio (M‐H, Fixed, 95% CI)	1.44 [0.33, 6.29]
13 Neonatal infection	1	202	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
14 Neonatal jaundice	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	2.51 [1.09, 5.81]
15 Apgar score less than 7 at 1 minute	2	225	Risk Ratio (M‐H, Fixed, 95% CI)	1.14 [0.64, 2.05]